NCT02020122View on ClinicalTrials.gov

Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Pain
Interventions
DRUG

Duloxetine

duloxetine 60mg

DRUG

Pregabalin

pregabalin 150mg

DRUG

Placebo

non active placebo

Trial Locations (1)

Unknown

Rambam Health Care Campus, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT02020122 - Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles | Biotech Hunter | Biotech Hunter